VanEck Pharmaceutical ETF (PPH) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free PPH Stock Alerts $89.30 +0.74 (+0.84%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media VanEck Pharmaceutical ETF Short Interest DataCurrent Short Volume1,400,000 sharesPrevious Short Volume1,580,000 sharesChange Vs. Previous Month-11.39%Dollar Volume Sold Short$119.62 millionShort Interest Ratio / Days to Cover11.3Last Record DateApril 15, 2024Outstanding Shares5,940,000 sharesPercentage of Shares Shorted23.57%Today's Trading Volume75,769 sharesAverage Trading Volume142,293 sharesToday's Volume Vs. Average53% Short Selling VanEck Pharmaceutical ETF ? Sign up to receive the latest short interest report for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPPH Short Interest Over TimePPH Days to Cover Over TimePPH Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here VanEck Pharmaceutical ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,400,000 shares $119.62 million -11.4%N/A11.3 $85.44 3/31/20248,700 shares $789,090.00 -99.5%N/A0.1 $90.70 3/15/20241,570,000 shares $140.59 million -8.7%N/A13 $89.55 2/29/20241,720,000 shares $152.74 million +5.5%N/A14.9 $88.80 2/15/20241,630,000 shares $144.16 million -22.4%N/A14.9 $88.44 1/31/20242,100,000 shares $179.13 million -0.5%N/A18.6 $85.30 Get the Latest News and Ratings for PPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,110,000 shares $180.57 million +14.7%N/A19.3 $85.58 12/31/20231,840,000 shares $149.71 million -4.7%N/A16.5 $81.37 12/15/20231,930,000 shares $152.10 million -18.9%N/A18 $78.81 11/30/20232,380,000 shares $186.85 million -1.2%N/A21.7 $78.51 11/15/20232,410,000 shares $184.75 million +4.3%N/A20.9 $76.66 10/31/20232,310,000 shares $173.97 million +4.5%N/A18.7 $75.31 10/15/20232,210,000 shares $177.00 million -1.3%N/A17.3 $80.09 9/30/20232,240,000 shares $178.89 million -1.3%N/A17.2 $79.86 9/15/20232,270,000 shares $186.03 million -2.6%N/A16.7 $81.95 8/31/20232,330,000 shares $190.83 million +16.5%N/A17.2 $81.90 8/15/20232,000,000 shares $165.46 million -17.0%N/A15.6 $82.73 7/31/20232,410,000 shares $193.81 million -0.4%N/A19.2 $80.42 7/15/20232,420,000 shares $188.49 million +5.2%N/A20.7 $77.89 6/30/20232,300,000 shares $181.17 million +0.4%N/A20.1 $78.77 6/15/20232,290,000 shares $179.70 million +19.9%N/A21.6 $78.47 5/31/20231,910,000 shares $144.49 million -12.8%N/A16.6 $75.65 5/15/20232,190,000 shares $172.48 million -10.3%N/A16.7 $78.76 4/30/20232,440,000 shares $192.44 million +1.2%N/A17.7 $78.87 4/15/20232,410,000 shares $191.59 million +3.9%N/A14.3 $79.50 3/31/20232,320,000 shares $180.10 million +19.0%N/A14.4 $77.63 3/15/20231,950,000 shares $144.65 million -18.8%N/A12.1 $74.18 2/28/20232,400,000 shares $181.56 million +8.1%N/A15.1 $75.65 2/15/20232,220,000 shares $173.74 million -7.5%N/A15.4 $78.26 1/31/20232,400,000 shares $188.02 million -0.4%N/A16.8 $78.34 1/15/20232,410,000 shares $191.60 million +4.8%N/A17.1 $79.50 12/30/20222,300,000 shares $178.80 million -3.8%N/A18.4 $77.74 12/15/20222,390,000 shares $186.68 million +7.2%N/A16 $78.11 11/30/20222,230,000 shares $171.78 million +10.4%N/A14.5 $77.03 11/15/20222,020,000 shares $147.97 million +27.9%N/A12.5 $73.25 10/31/20221,580,000 shares $115.10 million +6.8%N/A10.1 $72.85 10/15/20221,480,000 shares $101.05 million No ChangeN/A8.8 $68.28 9/30/20222,150,000 shares $144.57 million +4.9%N/A13 $67.24 9/15/20222,050,000 shares $144.94 million -10.1%N/A13 $70.70 8/31/20222,280,000 shares $161.29 million +31.0%N/A12.7 $70.74The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. PPH Short Interest - Frequently Asked Questions What is VanEck Pharmaceutical ETF's current short interest? Short interest is the volume of VanEck Pharmaceutical ETF shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,400,000 shares of PPH short. Learn More on VanEck Pharmaceutical ETF's current short interest. What is a good short interest ratio for VanEck Pharmaceutical ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PPH shares currently have a short interest ratio of 11.0. Learn More on VanEck Pharmaceutical ETF's short interest ratio. Is VanEck Pharmaceutical ETF's short interest increasing or decreasing? VanEck Pharmaceutical ETF saw a drop in short interest in April. As of April 15th, there was short interest totaling 1,400,000 shares, a drop of 11.4% from the previous total of 1,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does VanEck Pharmaceutical ETF's short interest compare to its competitors? Here is how the short interest of companies compare to VanEck Pharmaceutical ETF: VanEck Biotech ETF (0.09%), Invesco S&P SmallCap Health Care ETF (0.03%), ProShares Ultra Nasdaq Biotechnology (2.28%), Principal Healthcare Innovators ETF (0.32%), Invesco Nasdaq Biotechnology ETF (1.75%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), JPMorgan Healthcare Leaders ETF (0.08%), ProShares UltraShort Nasdaq Biotechnology (7.88%), and iShares Biotechnology ETF (15.82%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short VanEck Pharmaceutical ETF stock? Short selling PPH is an investing strategy that aims to generate trading profit from VanEck Pharmaceutical ETF as its price is falling. PPH shares are trading up $0.74 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VanEck Pharmaceutical ETF? A short squeeze for VanEck Pharmaceutical ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PPH, which in turn drives the price of the stock up even further. How often is VanEck Pharmaceutical ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPH, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: BBH Short Interest Data PSCH Short Interest Data BIB Short Interest Data BTEC Short Interest Data IBBQ Short Interest Data FTXH Short Interest Data JDOC Short Interest Data BIS Short Interest Data IBB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PPH) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersProof that the Musk/Bezos rivalry is about to hit a new levelInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressUrgent Nvidia WarningAltimetryTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media